Pharmintechs Group is further investing in R&D to continuously innovate and develop new products. The company further expanded its product portfolio within the high-value solutions segment in the past six months: The new freeze prefillable polymer syringes are made for deep-cold drugs such as vaccines and therapeutics, that need to be stored and transported on dry ice at temperatures reaching -100°C. With this innovation, the market in this category and enables deep-cold medications to be marketed using prefillable syringes.
Staying ahead through innovation
